| Eicosapentaenoic acid reduces membrane fluidity, inhibits cholesterol domain formation, and normalizes bilayer width in atherosclerotic-like model membranes RP Mason, RF Jacob, S Shrivastava, SCR Sherratt, A Chattopadhyay Biochimica et Biophysica Acta (BBA)-Biomembranes 1858 (12), 3131-3140, 2016 | 167 | 2016 |
| Eicosapentaenoic acid and docosahexaenoic acid have distinct membrane locations and lipid interactions as determined by X-ray diffraction SCR Sherratt, RP Mason Chemistry and physics of lipids 212, 73-79, 2018 | 154 | 2018 |
| Omega-3 fatty acid fish oil dietary supplements contain saturated fats and oxidized lipids that may interfere with their intended biological benefits RP Mason, SCR Sherratt Biochemical and biophysical research communications 483 (1), 425-429, 2017 | 131 | 2017 |
| Eicosapentaenoic acid improves endothelial function and nitric oxide bioavailability in a manner that is enhanced in combination with a statin RP Mason, H Dawoud, RF Jacob, SCR Sherratt, T Malinski Biomedicine & Pharmacotherapy 103, 1231-1237, 2018 | 92 | 2018 |
| Eicosapentaenoic acid inhibits oxidation of ApoB-containing lipoprotein particles of different size in vitro when administered alone or in combination with atorvastatin active … RP Mason, SCR Sherratt, RF Jacob Journal of cardiovascular pharmacology 68 (1), 33-40, 2016 | 69 | 2016 |
| Eicosapentaenoic acid (EPA) has optimal chain length and degree of unsaturation to inhibit oxidation of small dense LDL and membrane cholesterol domains as compared to related … SCR Sherratt, RA Juliano, RP Mason Biochimica et Biophysica Acta (BBA)-Biomembranes 1862 (7), 183254, 2020 | 49 | 2020 |
| Role of omega-3 fatty acids in cardiovascular disease: the debate continues SCR Sherratt, P Libby, MJ Budoff, DL Bhatt, RP Mason Current atherosclerosis reports 25 (1), 1-17, 2023 | 45 | 2023 |
| Omega-3 and omega-6 fatty acids have distinct effects on endothelial fatty acid content and nitric oxide bioavailability SCR Sherratt, H Dawoud, DL Bhatt, T Malinski, RP Mason Prostaglandins, Leukotrienes and Essential Fatty Acids 173, 102337, 2021 | 44 | 2021 |
| Eicosapentaenoic acid inhibits oxidation of high density lipoprotein particles in a manner distinct from docosahexaenoic acid SCR Sherratt, RP Mason Biochemical and biophysical research communications 496 (2), 335-338, 2018 | 41 | 2018 |
| EPA and DHA containing phospholipids have contrasting effects on membrane structure SCR Sherratt, RA Juliano, C Copland, DL Bhatt, P Libby, RP Mason Journal of Lipid Research 62, 2021 | 39 | 2021 |
| Are dietary fish oil supplements appropriate for dyslipidemia management? A review of the evidence SCR Sherratt, M Lero, RP Mason Current opinion in lipidology 31 (2), 94-100, 2020 | 29 | 2020 |
| The nonlinear effect of alkyl chain length in the membrane interactions of phenolipids: Evidence by X‐ray diffraction analysis E Durand, RF Jacob, S Sherratt, J Lecomte, B Baréa, P Villeneuve, ... European journal of lipid science and technology 119 (8), 1600397, 2017 | 26 | 2017 |
| A biological rationale for the disparate effects of omega-3 fatty acids on cardiovascular disease outcomes SCR Sherratt, P Libby, DL Bhatt, RP Mason Prostaglandins, Leukotrienes and Essential Fatty Acids 182, 102450, 2022 | 24 | 2022 |
| Rationale for different formulations of omega-3 fatty acids leading to differences in residual cardiovascular risk reduction RP Mason, SCR Sherratt, RH Eckel Metabolism-Clinical and Experimental 130, 2022 | 21 | 2022 |
| Omega-3-fatty acids: do they prevent cardiovascular disease? RP Mason, SCR Sherratt, RH Eckel Best Practice & Research Clinical Endocrinology & Metabolism 37 (3), 101681, 2023 | 16 | 2023 |
| Comparative effects of mineral oil, corn oil, eicosapentaenoic acid, and docosahexaenoic acid in an in vitro atherosclerosis model SCR Sherratt, P Libby, DL Bhatt, RP Mason Journal of the American Heart Association 12 (7), e029109, 2023 | 13 | 2023 |
| Do patients benefit from omega-3 fatty acids? SCR Sherratt, RP Mason, P Libby, PG Steg, DL Bhatt Cardiovascular Research 119 (18), 2884-2901, 2023 | 12 | 2023 |
| Rosmarinic acid and its esters inhibit membrane cholesterol domain formation through an antioxidant mechanism based, in nonlinear fashion, on alkyl chain length SCR Sherratt, P Villeneuve, E Durand, RP Mason Biochimica et Biophysica Acta (BBA)-Biomembranes 1861 (3), 550-555, 2019 | 10 | 2019 |
| Eicosapentaenoic acid (EPA) reduces pulmonary endothelial dysfunction and inflammation due to changes in protein expression during exposure to particulate matter air pollution SCR Sherratt, P Libby, H Dawoud, DL Bhatt, T Malinski, RP Mason Biomedicine & Pharmacotherapy 162, 114629, 2023 | 9 | 2023 |
| Multi-scale analysis of habitat fragmentation on small-mammal abundance and tick-borne pathogen infection prevalence in Essex County, MA SD Mason, SCR Sherratt, SM Kruguer, M Muthersbaugh, JP Harris, ... Plos one 17 (6), e0269768, 2022 | 8 | 2022 |
